Cargando…

Feasibility Study on Using Dynamic Contrast Enhanced MRI to Assess the Effect of Tyrosine Kinase Inhibitor Therapy within the STAR Trial of Metastatic Renal Cell Cancer

Objective: To identify dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters predictive of early disease progression in patients with metastatic renal cell cancer (mRCC) treated with anti-angiogenic tyrosine kinase inhibitors (TKI). Methods: The study was linked to a phase II/III...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Jim, Palkhi, Ebrahim, Buckley, David L., Collinson, Fiona J., Ralph, Christy, Jagdev, Satinder, Vasudev, Naveen S., Swain, Jayne, Brown, Janet E., Wah, Tze Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306403/
https://www.ncbi.nlm.nih.gov/pubmed/34359384
http://dx.doi.org/10.3390/diagnostics11071302

Ejemplares similares